Ki Summary

Reaction Details

Report a problem with these data

Target

GTPase KRas [G12C]

Ligand

BDBM608870

Substrate/Competitor

n/a

Meas. Tech.

Scintillation Proximity Assay (SPA)

IC50

12500±n/a nM

Citation

Cotesta, S; Gerspacher, M; Leblanc, C; Lorthiois, EL; Liu, B; Machauer, R; Mah, R; Mura, C; Rigollier, P; Schneider, N; Stutz, S; Vaupel, A; Warin, N; Wilcken, R Pyrazolyl derivatives useful as anti-cancer agents US Patent US11702409 Publication Date 7/18/2023

More Info.:

Get all data from this article, Assay Method

GTPase KRas [G12C]

Name:

GTPase KRas [G12C]

Synonyms:

GTPase KRas (G12C) | KRAS | KRAS2 | RASK2 | RASK_HUMAN

Type:

Enzyme Catalytic Domain

Mol. Mass.:

21702.19

Organism:

Homo sapiens (Human)

Description:

P01116[G12C]

Residue:

189

Sequence:

MTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAG
QEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDL
PSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGC
VKIKKCIIM

BDBM608870

n/a

Name

BDBM608870

Synonyms:

US11702409, Example 20a | US11702409, Example 20b

Type

Small organic molecule

Emp. Form.

C26H25ClFN7O

Mol. Mass.

505.974

SMILES

Cc1c(c(nn1C1CC2(C1)CN(C2)C(=O)C=C)-c1cnc(N)c(F)c1)-c1c(Cl)c(C)cc2[nH]ncc12 |(-3.12,-2.83,;-1.65,-2.36,;-.41,-3.26,;.84,-2.36,;.36,-.89,;-1.18,-.89,;-1.95,.44,;-3.43,.84,;-3.03,2.33,;-1.55,1.93,;-4.52,2.73,;-4.12,4.22,;-2.64,3.82,;-5.21,5.3,;-6.7,4.91,;-4.81,6.79,;-5.9,7.88,;2.31,-2.83,;3.45,-1.8,;4.91,-2.28,;5.23,-3.78,;6.7,-4.26,;4.09,-4.81,;4.41,-6.32,;2.63,-4.34,;-.41,-4.8,;-1.74,-5.57,;-3.07,-4.8,;-1.74,-7.11,;-3.07,-7.88,;-.41,-7.88,;.93,-7.11,;2.39,-7.59,;3.3,-6.34,;2.39,-5.09,;.93,-5.57,)|

Structure